A new test, the Oncotype DX Prostate Cancer Test, developed by Genomic Health “can help distinguish aggressive prostate cancer from less threatening ones, potentially saving many men from unneeded operations for tumors that would never hurt them.” The New York Times explains that the number of men who...

An article in Renal & Urology News reports “Early findings from the first prospective U.S. trial of prostatic artery embolization (PAE) suggest this approach may be safe and effective for treating lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH).” While medications...

A new study in Radiology evaluates “the feasibility and safety of magnetic resonance (MR) imaging–guided laser-based thermotherapy in men with clinically low-risk prostate cancer and a concordant lesion at biopsy and MR imaging.” The procedure was “successfully completed in nine...